This document sets out the results of a study
aimed at estimating the therapeutic efficacy of
ivermectin as an adjuvant in the treatment of COVID-19
patients treated at the Specialty Hospital Vida Mejor of
the Institute of Social Security for Workers of the State
of Chiapas, ISSTECH, Mexico. Ivermectin as an
adjuvant in the treatment of COVID-19 patients is more
effective (92%) outpatient patients. In critical
hospitalized and severe hospitalized patients, ivermectin
had a significant impact, both in improving patients'
health and decreasing lethality
Keywords : Ivermectin, COVID-19, Efficacy.